Publicacións (62) Publicacións nas que participase algún/ha investigador/a

1989

  1. A comparative study of the bronchodilator effects of inhaled fenoterol and salbutamol aerosol in patients with asthma

    Anales de Medicina Interna, Vol. 6, Núm. 2, pp. 74-78

  2. AGENESIA DEL CUERPO CALLOSO. ESTUDIO RETROSPECTIVO DE 20 CASOS

    Revista Espanola de Pediatria, Vol. 45, Núm. 270, pp. 479-483

  3. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: Does acute hyperglycemia act through hypothalamic release of somatostatin?

    Neuroendocrinology, Vol. 49, Núm. 5, pp. 551-554

  4. Adenopatías tuberculosas inguinales y poliartritis: un caso de enfermedad de Poncet?

    Revista clinica espanola

  5. Administration of glucocorticoids and growth hormone (GH) secretion in man

    Recent advances in basic and clinical neuroendocrinology: proceedings of the 4th Meeting of the European Neuroendocrine Association. ICS864

  6. Arteritis de células gigantes y biopsia de la arteria temporal.

    Anales de Medicina Interna

  7. Association of alpha-1-antitrypsin deficiency and extrahepatic bile ducts hypoplasia

    Journal of Clinical Nutrition and Gastroenterology, Vol. 4, Núm. 3, pp. 139-141

  8. CA 15.3 behaviour in cystic breast disease.

    International Journal of Biological Markers

  9. CA 72.4 serum levels in 298 patients with non-malignant diseases

    International Journal of Biological Markers

  10. Cephapirin-induced neutropenia

    Chemotherapy, Vol. 35, Núm. 6, pp. 449-453

  11. Cholinergic receptor activation by pyridostigmine restores growth hormone (gh) responsiveness to gh releasing hormone administration in obese subjects: Evidence for hypothalamic somatostatinergic participation in the blunted gh release of obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 68, Núm. 2, pp. 290-293

  12. Circulating CA 15-3 antigen levels in non-mammary malignancies

    British Journal of Cancer, Vol. 59, Núm. 2, pp. 283-286

  13. Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases

    Breast Cancer Research and Treatment, Vol. 13, Núm. 2, pp. 123-133

  14. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease

    Cancer, Vol. 64, Núm. 8, pp. 1674-1681

  15. Cleaved prolactin and its 16k fragment are generated by an acid protease

    Endocrinology, Vol. 125, Núm. 4, pp. 1967-1972

  16. Clinical behaviour of prostatic specific antigen and prostatic acid phosphatase: A comparative study

    International Journal of Biological Markers, Vol. 4, Núm. 2, pp. 87-94

  17. Comportamiento de la laminina sérica en pacientes hepatópatas. Experiencia preliminar.

    Medicina clinica

  18. Comportamiento del CA 72.4 sérico en pacientes afectos de patologías no tumorales. Resultados preliminares.

    Medicina Clinica

  19. DIASTEMATOMIELIA CERVICODORSAL DE PRESENTACION EN UN ADULTO

    Neurologia, Vol. 4, Núm. 6, pp. 213-215

  20. Differential Effects of Direct and Indirectly Acting Cholinergic Agonists on Growth Hormone Release in Man, and Lack of Effect on Cortisol Secretion

    Journal of Neuroendocrinology, Vol. 1, Núm. 5, pp. 379-382